Related Experiment Video
Updated: Apr 19, 2026

Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates
Published on: October 25, 2018
STRIPAK components determine mode of cancer cell migration and metastasis
Chris D Madsen1, Steven Hooper2, Melda Tozluoglu3
11] Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields London WC2A 3LY, UK [2] Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5 2200 Copenhagen N, Denmark.
Abstract:
The contractile actomyosin cytoskeleton and its connection to the plasma membrane are critical for control of cell shape and migration. We identify three STRIPAK complex components, FAM40A, FAM40B and STRN3, as regulators of the actomyosin cortex. We show that FAM40A negatively regulates the MST3 and MST4 kinases, which promote the co-localization of the contractile actomyosin machinery with the Ezrin/Radixin/Moesin family proteins by phosphorylating the inhibitors of PPP1CB, PPP1R14A-D. Using computational modelling, in vitro cell migration assays and in vivo breast cancer metastasis assays we demonstrate that co-localization of contractile activity and actin-plasma membrane linkage reduces cell speed on planar surfaces, but favours migration in confined environments similar to those observed in vivo. We further show that FAM40B mutations found in human tumours uncouple it from PP2A and enable it to drive a contractile phenotype, which may underlie its role in human cancer.
Insights
The STRIPAK complex, including FAM40A and FAM40B, regulates cell shape and migration by controlling the actomyosin cytoskeleton. Mutations in FAM40B are linked to cancer by altering cell contractility.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- The actomyosin cytoskeleton and its plasma membrane linkage are crucial for cell shape and migration.
- The STRIPAK complex's role in regulating these processes is not fully understood.
Purpose of the Study:
- To investigate the role of STRIPAK complex components (FAM40A, FAM40B, STRN3) in regulating the actomyosin cortex.
- To elucidate the molecular mechanisms by which these components influence cell migration and cancer metastasis.
Main Methods:
- Identification of STRIPAK components as actomyosin regulators.
- Biochemical assays to study kinase regulation (MST3/MST4) and protein phosphorylation.
- Computational modeling, in vitro cell migration assays, and in vivo breast cancer metastasis assays.
- Analysis of FAM40B mutations in human tumors.
Main Results:
- FAM40A negatively regulates MST3/MST4 kinases, affecting actomyosin-Ezrin/Radixin/Moesin (ERM) protein co-localization via phosphorylation of PPP1CB/PPP1R14A-D.
- Co-localization of contractile activity and actin-plasma membrane linkage impacts cell migration speed differently on planar versus confined surfaces.
- FAM40B mutations in human tumors disrupt PP2A interaction, promoting a contractile phenotype linked to cancer progression.
Conclusions:
- STRIPAK complex components FAM40A and FAM40B are key regulators of the actomyosin cytoskeleton and cell migration.
- The interplay between actomyosin contractility and plasma membrane linkage influences cell motility in different environments.
- FAM40B's oncogenic potential is linked to its ability to drive contractility upon mutation.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chemotaxis and Direction of Cell Migration
Cytoskeletal Coordination in Cell Migration

